Emergent BioSolutions | EBS - Funcionários Número total

Preço das Ações
8.29
Mudança Diária
-0.15 -1.78%
Mensal
-24.84%
Anual
43.67%
Q1 Previsão
8.19




Funcionários Alterar Data
Acadia Pharmaceuticals 653 56 2024-12
Akebia Therapeutics 167 37 2023-12
ALKERMES 1.8K 300 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amarin 275 90 2023-12
ANI Pharmaceuticals 642 42 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Coherus Biosciences 306 53 2023-12
Emergent BioSolutions 1.6K 900 2023-12
Exact Sciences 6.9K 400 2024-12
Exelixis 1.15K 163 2025-12
Glaxosmithkline GBP 69.4K 20.7K 2022-12
Heron Therapeutics 126 77 2023-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
Lexicon Pharmaceuticals 285 150 2023-12
Lonza 17.49K 1.28K 2022-12
Merck 75K 3K 2024-12
Moderna 5.8K 200 2024-12
Myriad Genetics 2.7K 0 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Pacira 790 79 2024-12
Pfizer 81K 7K 2024-12
PTC Therapeutics 939 49 2024-12
Sanofi 84.59K 3.41K 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
United Therapeutics 1.3K 137 2024-12
Vanda Pharmaceuticals 203 87 2023-12
Xoma 13 1 2023-12